Royalty Report: Medical, Surgical, Supply – Collection: 203427

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 9

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 9

Primary Industries

  • Medical
  • Surgical
  • Supply
  • Device
  • Wound Care
  • implants
  • Injectibles
  • Orthopedic
  • Tissue

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 203427

License Grant
Licensor grants to Company, an affiliate, an exclusive, worldwide, non-transferable license, with the right to sublicense, to the Intellectual Property to make, have made, modify, import, use, offer to sell, sell and have sold Products and perform and have performed processes under the Intellectual Property, solely in the Field.  The parties are entering into a Stock Purchase Agreement of even date.
License Property
The intellectual property and patents include, but are not limited to, Purification of structurally ordered recombinant protein polymers, Construction of synthetic DNA and its use in large polypeptide synthesis, High molecular weight collagen-like protein polymers, Synthetic proteins as implantables, Protein-enriched thennoplastics, and, Tissue Adhesive Using Synthetic Crosslinking.
Field of Use
The Field shall mean human or veterinary applications involving treatment, repair and/or diagnosis of conditions of the spine; provided that with respect to any Intellectual Property covering covalently crosslinked or adhesive protein polymer formulations (including without limitation, drug delivery formulations) the Field shall mean all orthopaedic applications, including treatment or diagnosis of deformities of the musculoskeletal system, which includes all of the bones and cartilages of the body and associated muscle attachments.

The Company is to develop and commercialize an injectable protein-based formulation for the repair of spinal disks damaged either by injury or aging. Based on Licensor's proprietary tissue adhesive technology, the product under development has potential to be an effective outpatient surgical treatment for chronic low back pain.

IPSCIO Record ID: 369243

License Grant
For the CoSeal Sealant Units Exclusive Distribution, Sales and Marketing Rights,  Licensors of the United States, Switzerland and Canada grant
— a sole and exclusive license, with right to sublicense, under Licensor Patents and Trademarks to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Sealant Units in the Sealant Territory; and
— a non-exclusive license, with right to sublicense, under Licensor Know-How to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Sealant Units in the Sealant Territory during the term of this Distribution and License Agreement.

For the CoSeal Sealant Option, Licensor grants an option (the CoSeal Sealant Option)
— a sole and exclusive license, with right to sublicense, under Licensor Patents and Trademarks to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Sealant Units in Japan; and
— a non-exclusive license, with right to sublicense, under Licensor Know-How to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Sealant Units in Japan.

For the CoSeal Adhesion Prevention Units Exclusive Distribution, Sales and Marketing Rights, Licensor grants
— a sole and exclusive license, with right to sublicense, under Licensor Patents and Trademarks to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Adhesion Prevention Units in the Adhesion Prevention Territory; and
— a non-exclusive license, with right to sublicense, under Licensor Know-How to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Adhesion Prevention Units in the Adhesion Prevention Territory during the term of this Distribution and License Agreement.

For the CoSeal Adhesion Prevention Option, Licensor grants to an option (the CoSeal Adhesion Prevention Option)
— a sole and exclusive license, with right to sublicense, under Licensor Patents and Trademarks to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Adhesion Prevention Units in the United States; and
— a non-exclusive license, with right to sublicense, under Licensor Know-How to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Adhesion Prevention Units in the United States.

For the CoSeal Accessories Exclusive Rights, Licensor grants
— a sole and exclusive license, with right to sublicense, under Licensor Patents and Trademarks to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Accessories in the Field in the Territory; and
— a non-exclusive license, with right to sublicense, under Licensor Know-How to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import the CoSeal Accessories in the Field in the Territory.

License Property
The trademarks include COSEAL©, ADHIBIT™, and, ANGIOTECHKNOWLEDGY™.

CoSeal Ingredients shall mean the two derivatized polyethylene glycol ingredients, designated COH102 and COH206

CoSeal Adhesion Prevention Unit shall mean a CoSeal Adhesion Prevention Product sold in combination with a CoSeal Adhesion Prevention Device.

CoSeal Devices shall mean, collectively, as the context requires, both or either of the CoSeal Adhesion Prevention Devices and/or the CoSeal Sealant Devices.

CoSeal Unit shall mean, collectively, as the context requires, both or either of the CoSeal Sealant Unit and/or the CoSeal Adhesion Prevention Unit.

CoSeal Sealant Unit shall mean a CoSeal Sealant Product sold in combination with a CoSeal Sealant Device.

CoSeal Sealant Product shall mean a product containing the CoSeal Ingredients that is the subject matter of a Regulatory Filing for use as a tissue sealant, adhesive or glue, has been or is approved by one or more Regulatory Authorities for use as a tissue sealant, adhesive or glue, or that is in development or sold for use as a tissue sealant, adhesive or glue.

Field of Use
CoSeal is indicated for use in vascular reconstructions to achieve adjunctive ·hemostasis by mechanically sealing areas of leakage.  CoSeal is designed to rapidly seal tissue surfaces, suture lines and synthetic grafts during surgery.

Field shall mean human therapeutic use for any and all tissue sealing, adhesive, glue or adhesion prevention barrier indications but shall specifically exclude any use (i) in Hemostat indications; (ii) for tissue regeneration indications; (iii) as an osteobiologic for skeletal repair an non-pharmacologic devices for osteoarthritis treatment,; (iv) as a urinary incontinence product and for the treatment of urinary incontinence; or (v) as an ostomy product.

IPSCIO Record ID: 372627

License Grant
By the 2003 agreement, Licensor granted an exclusive worldwide sublicense for the Licensed Technology in the Field of Use and the Field of Extended Use.  This amended and restated agreement is to continue the Exclusive Sublicense with the amendments.

Licensor grants an exclusive worldwide license under the Licensed Technology to use, offer to sell, sell, and otherwise commercialize, solely in the Field of Use and the Field of Extended Use, Licensed Products which include rhPDGF-BB purchased from Licensor.

For the Sublicenses, Licensor grants the right to grant sublicenses under the Licensed Technology to Distributors to use, offer to sell and sell, in the Field of Use and the Field of Extended Use, Licensed Products purchased from Licensor.

License Property
Licensed Products means any product consisting essentially of rhPDGF-BB in the absence of other growth-promoting proteins and in combination with a synthetic or natural matrix, or any part thereof i.e., any product consisting essentially of rhPDGF-BB in the absence of other growth-promoting proteins without a matrix, or a synthetic or natural matrix alone, that is covered by the Licensed Patents; is developed through the use of a process that is covered by the Licensed Patents or could not be manufactured, used or sold without the incorporation or use in whole or in part of some or all of the Licensed Patents.

Proven rhPDGF technology is FDA approval of GEM 21S for periodontal bone regeneration suggests potential for efficacy in other bone and musculoskeletal applications.

Field of Use
GEM 21S was approved by the U.S. Food and Drug Administration the treatment of periodontal bone defects and gum tissue recession associated with periodontal disease.

GEM 21S® growth-factor enhanced matrix is indicated to treat the following periodontally related defects intrabony periodontal defects; furcation periodontal defects; and gingival recession associated with periodontal defects.

GEM 21S® growth-factor enhanced matrix combines a bioactive protein – highly purified rhPDGF-BB – with an osteoconductive matrix, ß-TCP.

GEM 21S® is the only dental therapy containing rhPDGF-BB, one of the main growth factors found in the human body and well known for its stimulatory role in wound healing.

This completely synthetic grafting system is engineered to stimulate wound healing and bone regeneration when implanted in the body by triggering a cascade of molecular events that continues on even after the implanted rhPDGF-BB is gone.

The Field of Use means all uses related to the treatment, cure, or relief of mammals for periodontal diseases and/or the repair, restoration or reconstruction of oral and cranio• maxillofacial osseous defects.

The Field of Extended Use shall mean all uses outside the Field of Use that are related to the treatment and healing of bone, cartilage, tendon and ligaments of the skeletal tissue system in animals, excluding humans, excluding the treatment and healing of soft tissue wounds.

IPSCIO Record ID: 27345

License Grant
The Company has been granted three United States patents relating to the use of tissue on a removable backing which cover the sleeve configuration of Peri- Strips, the combination of tissue with a surgical stapling gun, and methods of performing a surgical procedure to remove diseased tissue.
License Property
Patent relates to Peri-Strips Dry covering the application of buttressing material (tissue or other synthetic material) onto a surgical stapler for purposes of reinforcing a surgical fastener suture line utilizing an adhesive substance and a positional and pressure equalization device to accomplish the adherence of the tissue to the surgical suturing device.

IPSCIO Record ID: 279379

License Grant
Licensor shall grant to Licensee and Affiliates under CyroSeal II Intellectual Property, and for the life of such CyroSeal II Intellectual Property, a non-exclusive, royalty bearing, license to make, use, offer to sell, sell, and import Products throughout the Territory for use in the Field of Use. Licensee shall have the right to grant sublicenses to others under the CyroSeal II Intellectual Property to import, distribute, offer to sell, sell, and obtain regulatory clearances for Products.
License Property
Product(s) means a fibrinogen concentration kit containing Licensor’s CryoSeal II Kit (minus Fibrinogen Reagent) and Licensee’s Plasma Fractioning Tube, ACD-A anti-coagulant, labeling per Licensee’s direction, and instructions.

CryoSeal II Kit is known as a product which harvests a fibrinogen rich solution of adhesive & clotting proteins.

CryoSeal II Kit means Licensor’s fibrinogen plus disposable, labeling as specified by Licensee, and applicators contained in a sterile package.

CyroSeal II Intellectual Property means Licensors Intellectual Property required to make, use, offer for sell, sell, and import the Product.

Field of Use
This agreement pertains to the drug industry relating to products that process autologous human cells, such as contained in blood, to product therapeutic products.   Field of Use means surgical hemostats, graft delivery systems, and surgeries.

The product will feature a fibrinogen harvesting disposable in combination with Licensee's Clotalyst(TM) System that can produce fibrin sealant from a patient's own blood in less than 30 minutes. Fibrin sealant is an adhesive gel used by surgeons to stop bleeding and bond tissue.

Licensee plans to combine Licensor's protein harvesting technology with its currently offered and future autologous therapies to manufacture autologous fibrin sealant in a peri-operative setting.

The product will feature a fibrinogen harvesting disposable in combination with Licensee's Clotalyst(TM) System that can produce fibrin sealant from a patient's own blood in less than 30 minutes. Fibrin sealant is an adhesive gel used by surgeons to stop bleeding and bond tissue.

IPSCIO Record ID: 282939

License Grant
The University hereby grants to Licensee a royalty-bearing, exclusive right and license under Licensed Subject Matter to manufacture, have manufactured, use and sell Licensed Products, to practice any method, process or procedure within the Patent Rights or the Technology Rights, and to otherwise exploit the Licensed Subject Matter, within the Licensed Territory for use within the Licensed Field.
License Property
U.S. 843,485 – Photopolymerizable Biodegradable Hydrogels as Tissue Contracting Materials and Controlled-Release Carriers

Technology Rights shall mean any and all rights in any technical information, know-how, process, procedure, composition, device, method, formula, protocol, technique, software, design, drawing or data relating to biomedical hydrogels or surface coatings which is not covered by the Patent Rights but which is necessary for practicing an invention, discovery or information covered by the Patent Rights, conceived or reduced to practice either prior to the effective date, or after the effective date and arising out of or in connection with the research program, and which Board has or may have the right to license or sublicense to Licensee under this License Agreement.

Field of Use
Licensed Field shall mean treatment of any medical condition of humans including without limitation treatment of post-surgical adhesions and other fibrosis or scarring conditions, treatment by means of leave-behind materials after open and other less invasive surgical procedures (such as localized drug delivery vehicles, adhesives, sealers, glues and polymers) treatment by means of localized drug release, and treatment by arterial plugging after angioplasty or other percutaneous procedures in interentional cardiology by means of angioplasty catheters of any type.

The Licensee develops, manufactures and commercializes synthetic, absorbable, liquid surgical sealants based on the Company's proprietary polymer technology.

IPSCIO Record ID: 28299

License Grant
The Licensor grants the Licensee an exclusive, worldwide right and license under the Licensed IP, to make, have made, use, sell, offer for sale, sublicense, have sold, import and have imported Licensed Products in Licensee and Licensor fields of use, and to modify and create derivatives for the treatment of spinal disorders.
License Property
The Licensor owns certain inventions, patents, patent applications, and other technical data and information for the treatment of spinal disorders.

“Licensed IF” means the Licensed Patents, Patent Applications and Inventions and all know-how, namely, technical information, manufacturing techniques and other intellectual property rights relating to the inventions covered by the Licensed Patents, and all other patents, patent applications, inventions or other intellectual property rights of Vertegen existing as of the date hereof that are required for ConforMIS’ exploitation of the licenses granted herein.

“ConforMIS Field of Use” means the diagnosis, assessment and treatment of articular disorders by the therapeutic use of Articular Repair Systems, including related current

“Articular Repair Systems” means any current or future devices or systems for the treatment of articular conditions or disorders, including without limitation implants made of metal, plastic, polymers, liquid metal or other suitable material; injectable solutions; self-expandable devices; inflatable devices; matrices and similar systems; hydrogels and similar systems; biological repair materials or kits; bio-resorbable materials or devices; surgical instruments; surgical planning techniques; and combinations of drugs and devices or combinations of different materials including biologies and non-biologics. “Articular Repair Systems” specifically excludes Spinal Repair Systems and the treatment of spinal disorders.

Title Devices and Methods for Treating Facet Joints,
Uncovertebral Joints, Costovertebral Joints and Other
Joints Serial No. 11/602,713

Title Devices and Methods for Treating Facet Joints,
Uncovertebral Joints, Costovertebral Joints and Other Joints
Application No. PCT/US2006/045131

Title U.S. Provisional Patent Application for Devices
and Methods for Treating Facet Joints, Uncovertebral Joints,
Costovertebral Joints and Other

Field of Use
Licensor field means the diagnosis, assessment, monitoring, surgical or interventional planning and treatment of spinal disorders by the therapeutic use of Spinal Repair Systems.
Licensee field means the diagnosis, assessment and treatment of articular disorders by the therapeutic use of Articular Repair Systems, including related current and future imaging techniques and other current and future approaches for implant sizing, shaping, selection, placement or manufacture.

IPSCIO Record ID: 3489

License Grant
The Company announced today that it received a ruling from the U.S. District Court in regards to ongoing royalty rates for Phase I of its patent litigation with Plaintiff. As previously announced, Phase 2 surrounding the cervical plates involved in the dispute was settled.
License Property
On August 17, 2012, Plaintiff filed additional patent claims in the U.S. District Court for the Northern District of Indiana alleging that the Company various spinal implants (including its CoRoent® XL family of spinal implants) infringe U.S. Patent No. 8,021,430, and that the Company's Osteocel® Plus bone graft product infringes U.S. Patent No. 5,676,146 C2. On August 28, 2012, Plaintiff amended its complaint in the Northern District of Indiana alleging that NuVasive's XLIF® procedure and use of MaXcess IV retractor during the XLIF procedure infringe methodology claims of U.S. Patent No. 8,251,997.
Field of Use
The CoRoent XL is a family of spinal implants used to replace weakened or damaged intervertebral discs. These discs act as the spine’s shock absorber allowing forces to be distributed evenly during the body’s movements.

And MaXcess instruments provide access to the spine in a manner that affords direct visualization and our nerve monitoring systems assist surgeons in avoiding critical nerves.  Our MaXcess system consists of instrumentation and specialized implants that provide maximum access to the spine with minimal soft tissue disruption. MaXcess has a split blade design consisting of three blades that can be positioned to build the surgical exposure in the shape and size specific to the surgical requirements rather than the fixed tube design of other minimally invasive surgical systems. MaXcess’ split blade design also provides expanded access to the spine, which allows surgeons to perform surgical procedures using instruments that are similar to those used in open procedures but with a significantly smaller incision. The ability to use familiar instruments reduces the learning curve and facilitates the adoption of our products. Our system’s illumination of the operative corridor aids in providing surgeons with direct visualization of the patient’s anatomy, without the need for additional technology or other special equipment.

IPSCIO Record ID: 27776

License Grant
The Licensor grants the Licensee an exclusive, worldwide right and license under the Licensed IP, to make, have made, use, sell, offer for sale, sublicense, have sold, import and have imported Licensed Products in Licensee and Licensor fields of use, and to modify and create derivatives for the treatment of spinal disorders.
License Property
The Licensor owns certain inventions, patents, patent applications, and other technical data and information for the treatment of spinal disorders.

“Licensed IF” means the Licensed Patents, Patent Applications and Inventions and all know-how, namely, technical information, manufacturing techniques and other intellectual property rights relating to the inventions covered by the Licensed Patents, and all other patents, patent applications, inventions or other intellectual property rights

“ConforMIS Field of Use” means the diagnosis, assessment and treatment of articular disorders by the therapeutic use of Articular Repair Systems, including related current and future imaging techniques and other current and future approaches for implant sizing, shaping, selection, placement or manufacture.

“Articular Repair Systems” means any current or future devices or systems for the treatment of articular conditions or disorders, including without limitation implants made of metal, plastic, polymers, liquid metal or other suitable material; injectable solutions; self-expandable devices; inflatable devices; matrices and similar systems; hydrogels and similar systems; biological repair materials or kits; bio-resorbable materials or devices; surgical instruments; surgical planning techniques; and combinations of drugs and devices or combinations of different materials including biologies and non-biologics. “Articular Repair Systems” specifically excludes Spinal Repair Systems and the treatment of spinal disorders.

Title Devices and Methods for Treating Facet Joints,
Uncovertebral Joints, Costovertebral Joints and Other
Joints Serial No. 11/602,713
Filing Date November 21, 2006

Title Devices and Methods for Treating Facet Joints,
Uncovertebral Joints, Costovertebral Joints and Other Joints
Application No. PCT/US2006/045131
Filing Date November 21, 2006

Title U.S. Provisional Patent Application for Devices
and Methods for Treating Facet Joints, Uncovertebral Joints,
Costovertebral Joints and Other Joints
Serial No. 60/740,323

Field of Use
Licensor field means the diagnosis, assessment, monitoring, surgical or interventional planning and treatment of spinal disorders by the therapeutic use of Spinal Repair Systems.

Licensee field means the diagnosis, assessment and treatment of articular disorders by the therapeutic use of Articular Repair Systems, including related current and future imaging techniques and other current and future approaches for implant sizing, shaping, selection, placement or manufacture.

Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.